The challenges of measuring disability accumulation in relapsing-remitting multiple sclerosis: evidence from interferon beta treatments. Kieseier BC Expert Rev Neurother. 2014 Jan; 14(1):105-20. PMID: 24417500. Abstract CommentRecommendBookmarkWatch